Possible peripheral mechanism for taste disorder in rats administered S-1
- 4 June 2013
- journal article
- Published by Springer Nature in International Journal of Clinical Oncology
- Vol. 19 (3) , 549-556
Abstract
Taste disorders are frequently observed in cancer patients undergoing chemotherapy and are serious adverse events which impair the quality of life (QoL) of the cancer patient. Nevertheless, taste disorder mechanisms in cancer patients undergoing chemotherapy have not yet been fully elucidated. The aim of this study was to reveal taste disorder-related peripheral mechanisms using the two-bottle preference test (TBPT) and histological examination of tongues by hematoxylin–eosin staining and immunohistochemistry with protein-gene product 9.5. In the TBPT, one bottle was filled with the 0.01 mM quinine hydrochloride (quinine), as a bitter compound, and the other was filled with water. Doses of 50 and 100 mg kg−1 day−1 S-1 (tegafur/gimeracil/oteracil potassium) are lethal to Wistar rats. Therefore, doses ranging from 2–20 mg kg−1 day−1 were administered to the rats for 3 weeks. The S-1 dose of 2 mg kg−1 day−1 corresponds to the clinical dose administered to cancer patients. The part of the tongue containing the circumvallate papillae was excised the following TBPT. The rate of increase in terms of the average preference rate for the quinine vs. all intake (quinine plus water) was significant from the initial S-1 period to the final one, compared with that in control rats, suggesting the possibility of a worsening sensation for the bitter taste. In S-1 rats, the area of taste nerve fibers were significantly decreased and the rate of degeneration of intra-tongue ganglionic nerve cells was significantly increased. These changes were significantly correlated with the rate of increase in average preference rate of the quinine. Neuropathy of the gustatory nerve at the periphery may be involved in taste disorders induced by an anticancer drug.Keywords
This publication has 21 references indexed in Scilit:
- Functional bitter taste receptors are expressed in brain cellsBiochemical and Biophysical Research Communications, 2011
- Effects of polaprezinc on morphological change of the tongue in zinc-deficient ratsJournal of Oral Pathology & Medicine, 2010
- A systematic review of dysgeusia induced by cancer therapiesSupportive Care in Cancer, 2010
- An Open-Label Controlled Trial of Theophylline for Treatment of Patients With HyposmiaThe American Journal of the Medical Sciences, 2009
- Taste and smell alterations in cancer patients--real problems with few solutions.2009
- Qualitative and Quantitative Assessment of Taste and Smell Changes in Patients Undergoing Chemotherapy for Breast Cancer or Gynecologic MalignanciesJournal of Clinical Oncology, 2009
- cAMP and cGMP in nasal mucus: relationships to taste and smell dysfunction, gender and ageClinical & Investigative Medicine, 2008
- cAMP and cGMP in Human Parotid Saliva: Relationships to Taste and Smell Dysfunction, Gender, and AgeThe American Journal of the Medical Sciences, 2007
- Long-Term Zinc Deficiency Decreases Taste Sensitivity in RatsThe Journal of Nutrition, 2001
- Neural responses to bitter compounds in ratsBrain Research, 1997